Lupus arthritis--do we have a clinically useful classification?
暂无分享,去创建一个
[1] T. Vischer,et al. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. , 1993, The Journal of rheumatology.
[2] E. Sato,et al. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. , 1999, The Journal of rheumatology.
[3] B. Cruickshank. Lesions of Joints and Tendon Sheaths in Systemic Lupus Erythematosus , 1959 .
[4] D. Isenberg,et al. B-cell-depletion therapy in SLE—what are the current prospects for its acceptance? , 2009, Nature Reviews Rheumatology.
[5] P. Spronk,et al. Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response? , 1992, Annals of the rheumatic diseases.
[6] E. Borba,et al. Spontaneous tendon rupture in systemic lupus erythematosus: association with Jaccoud’s arthropathy , 2010, Lupus.
[7] A. Cotten,et al. MR imaging findings in hands in early rheumatoid arthritis: comparison with those in systemic lupus erythematosus and primary Sjögren syndrome. , 2005, Radiology.
[8] L. Amezcua-Guerra. Overlap Between Systemic Lupus Erythematosus and Rheumatoid Arthritis: Is It Real or Just an Illusion? , 2009, The Journal of Rheumatology.
[9] P. Askenase,et al. Valvular heart disease in patients with hypocomplementemic urticarial vasculitis syndrome associated with Jaccoud's arthropathy. , 2002, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[10] J. Ioannidis,et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics , 2007, Annals of the rheumatic diseases.
[11] M. Schneider,et al. EULAR-Empfehlungen zur Behandlung des systemischen Lupus erythematodes , 2009, Zeitschrift für Rheumatologie.
[12] C. Gordon,et al. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. , 2009, Rheumatology.
[13] J. Bijlsma,et al. Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus , 1998, Annals of the rheumatic diseases.
[14] N. McHugh,et al. Arthropathy of hands and feet in systemic lupus erythematosus. , 1990, The Journal of rheumatology.
[15] R. Edwards,et al. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. , 2006, Rheumatology.
[16] A. Tzioufas,et al. Sialochemistry in juvenile chronic arthritis. , 1989, British journal of rheumatology.
[17] A. Iagnocco,et al. Imaging Ultrasound imaging for the rheumatologist XXIV . Sonographic evaluation of wrist and hand joint and tendon involvement in systemic lupus erythematosus , 2006 .
[18] M. Santiago,et al. Jaccoud Arthropathy in Systemic Lupus Erythematosus: Analysis of Clinical Characteristics and Review of the Literature , 2008, Medicine.
[19] Geoffrey Hom,et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. , 2008, The New England journal of medicine.
[20] J. Decker,et al. Deforming non-erosive arthritis of the hand in systemic lupus erythematosus. , 1974, Clinical Orthopaedics and Related Research.
[21] Pinals Rs,et al. Jaccoud's arthropathy in scleroderma. , 1984 .
[22] I Cavazzana,et al. Mechanisms of immune-mediated skin diseases: an overview. , 2006, Clinical and experimental rheumatology.
[23] A. Mimori,et al. Clinical and immunological features of systemic lupus erythematosus complicated by Jaccoud's arthropathy , 2001, Modern rheumatology.
[24] D. Deforce,et al. Proteomics in rheumatology: The beginning of a fairy tale? , 2008, Proteomics. Clinical applications.
[25] W. Grassi,et al. Hand Arthritis in Systemic Lupus Erythematosus: An Ultrasound Pictorial Essay , 2006, Lupus.
[26] J. Grossman,et al. Lupus arthritis. , 2009, Best practice & research. Clinical rheumatology.
[27] K. Bloch,et al. Hypocomplementemic urticarial vasculitis, jaccoud's arthropathy, valvular heart disease, and reversible tracheal stenosis: a surfeit of syndromes. , 2001, The Journal of rheumatology.
[28] R. Grahame,et al. Chronic post-rheumatic fever (Jaccoud's) arthropathy. , 1970, Annals of the rheumatic diseases.
[29] X. Yang,et al. Anti-TNF-α Therapies in Systemic Lupus Erythematosus , 2010, Journal of Biomedicine and Biotechnology.
[30] E. Cholongitas,et al. Deforming arthropathy in systemic lupus erythematosus. , 2008, European journal of internal medicine.
[31] A. Iagnocco,et al. Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study. , 2004, Clinical and experimental rheumatology.
[32] M. Calaza,et al. Replication of recently identified systemic lupus erythematosus genetic associations: a case–control study , 2009, Arthritis research & therapy.
[33] G. Rodnan,et al. Experience with punch biopsy of synovium in the study of joint disease. , 1960, Annals of internal medicine.
[34] D. Resnick,et al. "Hook" erosions in Jaccoud's arthropathy. , 1980, Journal of the Canadian Association of Radiologists.
[35] M. Aringer,et al. Use of methotrexate in patients with systemic lupus erythematosus and primary Sjögren's syndrome. , 2010, Clinical and experimental rheumatology.
[36] D. Isenberg,et al. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis , 2001, Annals of the rheumatic diseases.
[37] D. Alarcón-Segovia,et al. Deforming arthropathy of the hands in systemic lupus erythematosus. , 1988, The Journal of rheumatology.
[38] Y. Qing,et al. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus , 2009, Lupus.
[39] S. Hayat,et al. Efficacy and safety of infliximab in active SLE: a pilot study , 2009, Lupus.
[40] M. Aringer,et al. Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus. , 2008, Expert opinion on drug safety.
[41] D. C. Graham,et al. Genome-wide association studies in systemic lupus erythematosus: a perspective , 2009 .
[42] M. Petri. Clinical features of systemic lupus erythematosus , 1993, Current opinion in rheumatology.
[43] M. Aringer,et al. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. , 2004, Arthritis and rheumatism.
[44] E. Matteson,et al. Lupus arthropathy: a case series of patients with rhupus , 2006, Clinical Rheumatology.
[45] M. Aringer,et al. Therapeutic blockade of TNF in patients with SLE-promising or crazy? , 2012, Autoimmunity reviews.
[46] David Altshuler,et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus , 2008, Nature Genetics.
[47] D. Isenberg,et al. Clinical utility and serological connections of anti-RA33 antibodies in systemic lupus erythematosus. , 1994, The Journal of rheumatology.
[48] K. N. Verpoort. Anti-citrullinated peptide antibodies in rheumatoid arthritis and undifferentiated arthritis , 2008 .
[49] E. C. Han. Systemic Lupus Erythematosus , 2012 .
[50] M. Santiago,et al. Iconography : Magnetic resonance imaging of Jaccoud’s arthropathy in systemic lupus erythematosus , 2010 .
[51] A. Tan,et al. What magnetic resonance imaging has told us about the pathogenesis of rheumatoid arthritis – the first 50 years , 2008, Arthritis research & therapy.
[52] M. Ramos-Casals,et al. Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases , 2009, Lupus.
[53] M. Motta,et al. Profile of autoantibodies in Jaccoud's arthropathy. , 2009, Joint, bone, spine : revue du rhumatisme.
[54] Y. Miyachi,et al. Hypocomplementaemic urticarial vasculitis associated with Jaccoud's syndrome , 1997, The British journal of dermatology.
[55] E. Chan,et al. Citrulline Dependence of Anti-Cyclic Citrullinated Peptide Antibodies in Systemic Lupus Erythematosus as a Marker of Deforming/Erosive Arthritis , 2009, The Journal of Rheumatology.
[56] P. Lipsky,et al. Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. , 2010, Arthritis and rheumatism.
[57] R. Dhawan. Associations of Erosive Arthritis with Anti-Cyclic Citrullinated Peptide Antibodies and MHC Class II Alleles in Systemic Lupus Erythematosus , 2009 .
[58] M. Petri,et al. Novel evidence-based systemic lupus erythematosus responder index. , 2009, Arthritis and rheumatism.
[59] D. C. Cunninghame Graham. Genome-wide association studies in systemic lupus erythematosus: a perspective , 2009, Arthritis research & therapy.
[60] C. Langefeld,et al. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies , 2009, Nature Reviews Genetics.
[61] R. Cattaneo,et al. Deforming Arthropathy of the Hands in Systemic Lupus Erythematosus is Associated with Antibodies to SSA/Ro and to SSB/La , 1994, Lupus.
[62] Matthias Schneider,et al. Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. , 2003, Arthritis and rheumatism.
[63] C. Gordon,et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. , 2010, Arthritis and rheumatism.
[64] D. Isenberg,et al. Erosive arthritis in systemic lupus erythematosus: analysis of a distinct clinical and serological subset. , 1998, British journal of rheumatology.
[65] D. Tuffanelli,et al. CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. , 1964, JAMA.
[66] J. Nossent,et al. Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus , 2011, Lupus.
[67] J. Cabiedes,et al. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy , 2008, Lupus.
[68] M. Petri,et al. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. , 2009, Arthritis and rheumatism.
[69] J. Esdaile,et al. Deforming arthritis in systemic lupus erythematosus. , 1981, Annals of the rheumatic diseases.
[70] Chandra Mohan,et al. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. , 2005, The Journal of clinical investigation.
[71] E. Huskisson. JACCOUD'S SYNDROME , 1987 .
[72] D. Kimpel. Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis , 2008 .
[73] L. Saketkoo,et al. Revisiting Jaccoud Arthropathy as an Ultrasound Diagnosed Erosive Arthropathy in Systemic Lupus Erythematosus , 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[74] E. Matteson,et al. Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. , 2007, Clinical and experimental rheumatology.
[75] M. Abrahamowicz,et al. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. , 2008, Arthritis and rheumatism.
[76] S. Özen,et al. Musculoskeletal sonography in juvenile systemic lupus erythematosus , 2008, Pediatric Rheumatology Online Journal.
[77] A. Zoma. Musculoskeletal involvement in systemic lupus erythematosus , 2004, Lupus.